The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis

被引:1
作者
Kadota, Jun-ichi
Mizunoe, Syunji
Mukae, Hiroshi
Mito, Katsuhiko
Kishi, Kenji
Tokimatsu, Issei
Nagai, Hiroyuki
Tomono, Kazunori
Kohno, Shigeru
Nasua, Masaru
机构
[1] Oita Univ, Fac Med, Dept Infect Dis, Div Pathogenesis & Dis Control, Oita 8795593, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med, Nagasaki 852, Japan
关键词
apoptosis; Bax; Bcl-2; caspase-3; lung tissue; diffuse panbronchiolitis;
D O I
10.1016/j.rmed.2006.02.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diffuse panbronchiolitis (DPB) is a distinctive form of small airway disease, which is characterized by chronic inflammation with lymphocyte infiltration around bronchioles. The aim of this study was to evaluate the importance of factors related to apoptosis in peribronchiolar lymphocytes of DPB. We employed immunohistochemical methods for the localization of Bax (a promoter of apoptosis), Bcl-2 (an inhibitor of apoptosis), and caspase-3 (a key executioner molecule of apoptosis) in lung tissues of five patients with DPB. In all patients, immunostaining for Bax was almost completely absent in accumulated lymphocytes around the bronchioles and in lymphocytes of the parafollicular area that correspond to a zone populated by T cells. In contrast to the reaction for Bax, Bcl-2 immunoreactivity was uniformly strong in all of the patients. The pattern of staining for caspase-3 was similar to that for Bax in all of the patients. In normal lung tissue, a few lymphocytes showed negative immunostaining for BcL-2 and a positive reaction for caspase-3. Our results suggest that Bcl-2 protein may provide T-lymphocyte survival and hypercellularity in the bronchioles, thereby contributing to the progression of DPB. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2029 / 2036
页数:8
相关论文
共 30 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] The apoptotic syndromes
    Andreoli, TE
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 107 (05) : 488 - 488
  • [3] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [4] COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
  • [5] DIFFUSE PANBRONCHIOLITIS - A DISEASE OF THE TRANSITIONAL ZONE OF THE LUNG
    HOMMA, H
    YAMANAKA, A
    TANIMOTO, S
    TAMURA, M
    CHIJIMATSU, Y
    KIRA, S
    IZUMI, T
    [J]. CHEST, 1983, 83 (01) : 63 - 69
  • [6] DIFFUSE PANBRONCHIOLITIS - DIAGNOSIS AND DISTINCTION FROM VARIOUS PULMONARY-DISEASES WITH CENTRILOBULAR INTERSTITIAL FOAM CELL ACCUMULATIONS
    IWATA, M
    COLBY, TV
    KITAICHI, M
    [J]. HUMAN PATHOLOGY, 1994, 25 (04) : 357 - 363
  • [7] DIFFUSE PANBRONCHIOLITIS
    IZUMI, T
    [J]. CHEST, 1991, 100 (03) : 596 - 597
  • [8] In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes
    Jun, YT
    Kim, HJ
    Song, MJ
    Lim, JH
    Lee, DG
    Han, KJ
    Choi, SM
    Yoo, JH
    Shin, WS
    Choi, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 1161 - 1164
  • [9] Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
    Juo, P
    Kuo, CJ
    Yuan, JY
    Blenis, J
    [J]. CURRENT BIOLOGY, 1998, 8 (18) : 1001 - 1008
  • [10] A MECHANISM OF ERYTHROMYCIN TREATMENT IN PATIENTS WITH DIFFUSE PANBRONCHIOLITIS
    KADOTA, J
    SAKITO, O
    KOHNO, S
    SAWA, H
    MUKAE, H
    ODA, H
    KAWAKAMI, K
    FUKUSHIMA, K
    HIRATANI, K
    HARA, K
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01): : 153 - 159